Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81072400)
This publication has 104 references indexed in Scilit:
- High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic FactorPLOS ONE, 2013
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapyJournal of Experimental Medicine, 2011
- IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and functionEuropean Journal of Immunology, 2010
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patientsLung Cancer, 2010
- Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesisProceedings of the National Academy of Sciences, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ productionProceedings of the National Academy of Sciences, 2009
- An overview of IL-17 function and signalingCytokine, 2008
- Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4 − NK1.1 − NKT cell populationProceedings of the National Academy of Sciences, 2008
- Inflammation and cancerNature, 2002